//4column



//STUDYID	Ananth 2002		
//URL			
//Title	Cortical and Subcortical Gray Matter Abnormalities in Schizophrenia Determined Through Structural Magnetic Resonance Imaging With Optimized Volumetric Voxel-Based Morphometry		
//CORRECTED			
//TAL			
//DESCRIPTION	TABLE 2. Regional Differences in Gray and White Matter Volume Between 20 Patients With Schizophrenia and 20 Matched Comparison Subjects 		
//STRUCTURAL			
//NO_FLIPX			
//CENSOR=			
//COVARIATE=			
//TDOF=	38		
//CONTRASTID			
//CONDITIONID			
//			
//CONTROLS=	20		
//SUBJECTS=	20		
-8	-15	17	-7.7
45	-74	18	-7.52
2	63	14	-7.32
42	-5	65	-7.04
66	-35	-6	-7.03
-23	-74	-9	-6.92
-6	-75	18	-6.75
47	-20	68	-6.68
23	38	53	-6.62
51	-69	38	-6.61
-45	15	36	-6.61
-39	-5	68	-6.61
30	33	-9	-6.5


//STUDYID	Antonova 2005		
//URL			
//Title	The Relationship of Structural Alterations to Cognitive Deficits in Schizophrenia: A Voxel-Based Morphometry Study		
//CORRECTED			
//TAL			
//DESCRIPTION	Coordinates In text		
//STRUCTURAL			
//NO_FLIPX			
//CENSOR=			
//COVARIATE=			
//TDOF=	86		
//CONTRASTID			
//CONDITIONID			
//			
//CONTROLS=	43		
//SUBJECTS=	45		
-33	27	-8	-4.72
-22	-86	-9	-4.34


//STUDYID	Asami 2012		
//URL			
//Title	Longitudinal Loss of Gray Matter Volume in Patients with FirstEpisode Schizophrenia: DARTEL Automated Analysis and ROI Validation		
//CORRECTED			
//MNI			
//DESCRIPTION	Supplemental Table S1		
//STRUCTURAL			
//NO_FLIPX			
//CENSOR=			
//COVARIATE=			
//TDOF=	42		
//CONTRASTID			
//CONDITIONID			
//			
//CONTROLS=	23		
//SUBJECTS=	21		
-42	-10	-6	-3.8
-40	2	-18	-3.25
-30	-10	-16	-4.04
8	42	28	-3.94
0	-14	4	-5.04
-6	-86	6	-4.51



//STUDYID	Bassitt 2007		
//URL			
//Title	Insight and regional brain volumes in schizophrenia		
//CORRECTED			
//TAL			
//DESCRIPTION	Coordinates in text		
//STRUCTURAL			
//NO_FLIPX			
//CENSOR=			
//COVARIATE=			
//ZSCORE			
//CONTRASTID			
//CONDITIONID			
//			
//CONTROLS=	30		
//SUBJECTS=	50		
54	10	8	-4.18
-42	6	12	-4.69
56	-5	3	-5.05
-38	1	12	-4.87


//STUDYID	Cascella 2010		
//URL			
//Title	Gray-matter abnormalities in deficit schizophrenia		
//CORRECTED			
//TAL			
//DESCRIPTION	Table 2 HCNSZ (covariates: age, sex and TICV); FWE pb.05; ET=20		
//STRUCTURAL			
//NO_FLIPX			
//CENSOR=			
//COVARIATE=			
//TDOF=	138		
//CONTRASTID			
//CONDITIONID			
//			
//CONTROLS=	90		
//SUBJECTS=	50		
-34	34	-18	-5.66
38	20	-14	-6.93
-52	8	18	-5.82
24	40	44	-6.25
-2	30	42	-6.18
-4	54	2	-5.57
-58	2	-22	-6.2
-40	20	-8	-6.98
-32	-8	-46	-6.91
8	-70	40	-6.4
2	-92	6	-5.26
52	-60	-18	-5.93



//STUDYID	Chua	2006										
//URL												
//Title	Cerebral	grey,	white	matter	and	csf	in	never-medicated,	first-episode	schizophrenia		
//CORRECTED												
//TAL												
//DESCRIPTION	Table	3	Regional	grey	and	white	matter	deficits	in	FEP	(pb0.004)	
//STRUCTURAL												
//NO_FLIPX												
//CENSOR=	2.65											
//COVARIATE=												
//NOT_GIVEN												
//CONTRASTID												
//CONDITIONID												
//												
//CONTROLS=	38											
//SUBJECTS=	26											
2.6	14	1	-1									
1.4	-48.2	25	-1									
28.1	8.5	-19.6	-1									
-17.5	0.3	-22.5	-1									
-36.1	3.9	0.9	-1									
39.3	-0.6	3.4	-1									
-55.7	3.9	-4.6	-1									
-4.6	-49.7	-21.8	-1									
28.3	-42.7	-33.2	-1									
2.1	-46.3	37.8	-1									


//STUDYID	Donohoe 2011		
//URL			
//Title	ZNF804A risk allele is associated with relatively intact gray matter volume in patients with schizophrenia		
//CORRECTED			
//MNI			
//DESCRIPTION	Supplemental Table S1		
//STRUCTURAL			
//NO_FLIPX			
//CENSOR=			
//COVARIATE=			
//ZSCORE			
//CONTRASTID			
//CONDITIONID			
//			
//CONTROLS=	38		
//SUBJECTS=	70		
1	-14	34	-6.9
-47	-32	1	-6.27
22	20	36	-6.08
13	-26	4	-5.79
-59	-29	28	-5.62
32	7	27	-5.59
-13	-30	3	-5.58
25	-9	42	-5.57
9	58	-6	-5.38
-22	-3	43	-5.33




//STUDYID	Giuliani 2005		
//URL			
//Title	Voxel-based morphometry versus region of interest: a comparison of two methods for analyzing gray matter differences in schizophrenia		
//CORRECTED			
//TAL			
//DESCRIPTION	Table 2 Summary of areas detected in the main effects analyses		
//STRUCTURAL			
//NO_FLIPX			
//CENSOR=			
//COVARIATE=			
//TDOF=	73		
//CONTRASTID			
//CONDITIONID			
//			
//CONTROLS=	34		
//SUBJECTS=	41		
-13	56	-8	-6
22	59	5	-5.6
-56	23	3	-5.5
45	16	-3	-5.2
-3	8	-11	-4.1
-67	-9	14	-4.2
-49	10	-2	-4.8
46	10	-2	-5
-46	13	-7	-5.1
45	10	-4	-5.1
-1	4	-4	-5.4
4	23	24	-5.2
-3	-17	4	-5.5
4	-19	6	-5.4


//STUDYID	Garca-Mart 2008		
//URL			
//Title	Schizophrenia with auditory hallucinations: A voxel-based morphometry study		
//CORRECTED			
//MNI			
//DESCRIPTION			
//STRUCTURAL			
//NO_FLIPX			
//CENSOR=			
//COVARIATE=			
//TDOF=	35		
//CONTRASTID			
//CONDITIONID			
//			
//CONTROLS=	19		
//SUBJECTS=	18		
-43	12	-10	-5.84
45	16	-9	-5.1
57	-35	8	-3.87
-23	4	-22	-3.56
-37	8	-18	-3.51


//STUDYID	Honea 2008		
//URL			
//Title	Is Gray Matter Volume an Intermediate Phenotype for Schizophrenia? A VBM Study of Patients with Schizophrenia and their Healthy Siblings		
//CORRECTED			
//MNI			
//DESCRIPTION	Table 2 Summary of the results obtained by voxel-wise wtatistical analysis of the GM Maps of decreases in SCZ with NC		
//STRUCTURAL			
//NO_FLIPX			
//CENSOR=			
//COVARIATE=			
//ZSCORE			
//CONTRASTID			
//CONDITIONID			
//			
//CONTROLS=	212		
//SUBJECTS=	169		
-28	62	13	-7.58
30	63	1	-6.38
-2	52	41	-5.87
-4	35	40	-5.83
7	47	50	-5.66
-2	65	9	-4.82
-17	42	49	-5.55
52	18	3	-7.34
54	11	32	-5.17
58	-25	47	-5.15
-3	32	-26	-5.41
-41	13	-6	-10
-60	-49	6	-6.84
-57	-48	-23	-5.42
-20	-84	-10	-4.85
-48	-52	52	-4.94
54	-70	6	-5.75
-18	-94	-16	-5.08
23	-99	-4	-5.01
4	-20	-1	-7.1
-32	-84	-36	-5.12
35	-85	-35	-4.91

//STUDYID	Horn 2010		
//URL			
//Title	Gray matter volume differences specific to formal thought disorder in schizophrenia		
//CORRECTED			
//TAL			
//DESCRIPTION	Coordinates in text		
//STRUCTURAL			
//NO_FLIPX			
//CENSOR=			
//COVARIATE=			
//TDOF=	38		
//CONTRASTID			
//CONDITIONID			
//			
//CONTROLS=	20		
//SUBJECTS=	20		
15	68	4	-5.9
-50	8	7	-6.05

//STUDYID	Huang 2015			
//URL				
//Title	Decreased bilateral thalamic gray matter volume in frst-episode schizophrenia with prominent hallucinatory symptoms: A volumetric MRI study			
//CORRECTED				
//MNI		
//DESCRIPTION	Table 2. Brain clusters with signifcant gray matter volume changes			
//STRUCTURAL				
//NO_FLIPX				
//CENSOR=				
//COVARIATE=				
//NOT_GIVEN			
//CONTRASTID				
//CONDITIONID				
//				
//CONTROLS=	18			
//SUBJECTS=	18			
-45	6	-3	-1	
4	-16	2	-1	
-4	-16	6	-1	
45	22.5	-3	-1	
46.5	-7.5	31.5	-1	




//STUDYID	Hulshoff 2001		
//URL			
//Title	Focal Gray Matter Density Changes in Schizophrenia		
//CORRECTED			
//TAL			
//DESCRIPTION	Table 2 Focal Gray Matter Decreases 		
//STRUCTURAL			
//NO_FLIPX			
//CENSOR=			
//COVARIATE=			
//ZSCORE			
//CONTRASTID			
//CONDITIONID			
//			
//CONTROLS=	158		
//SUBJECTS=	159		
-15	-9	-15	-5.91
-17	-26	-11	-5.99
-35	17	-11	-7.28
-35	17	-1	-7.52
-3	-19	5	-6.3
-1	41	-13	-6.98
-43	41	13	-6.85
-5	24	35	-6.14
-39	-14	11	-6.67
-39	17	-17	-7.23
-1	-74	-1	-6.45
-3	-48	33	-5.95
-5	-62	17	-5.33
31	15	-9	-7.06
45	12	-1	-7.63
1	-19	5	-6.15
1	43	-13	-7.16
35	55	5	-7.68
3	36	37	-6.3
39	0	7	-6.96
37	19	-19	-7.02
1	-74	-1	-6.26
1	-48	33	-6.01
1	-60	21	-5.97
49	-26	51	-6.16


//STUDYID	Herold 2009		
//URL			
//Title	Regional gray matter reduction and theory of mind deficit in the early phase of schizophrenia: a voxel-based morphometric study		
//UNCORRECTED			
//MNI		
//DESCRIPTION	Table 2. Significant decrease in gray matter density in patients with schizophrenia compared with controls		
//STRUCTURAL			
//NO_FLIPX			
//CENSOR=	2.58		
//COVARIATE=			
//ZSCORE			
//CONTRASTID			
//CONDITIONID			
//			
//CONTROLS=	21		
//SUBJECTS=	18		
14	46	11	-3.78
11	43	-15	-3.75
11	50	-26	-3.71
57	5	-32	-3.44
45	-9	-31	-3.41
41	-4	-36	-3.36
-49	-7	-32	-3.3
-45	-5	-20	-3.11
-38	-13	-11	-2.98
-44	33	-2	-3.26
-38	29	6	-2.98
19	66	11	-3.25
33	-10	67	-3.24
20	-16	53	-3.19
9	-17	54	-2.88
64	-17	-28	-3.23
-15	-10	-30	-3.22
-23	54	-1	-3.21
-47	-30	4	-3.2
-57	19	1	-2.83
-19	45	-15	-3.17
-17	37	-16	-3.05
-15	54	-14	-2.98
-27	-59	-62	-3.16
-17	-55	-61	-2.92
-14	-75	-56	-2.9
-47	-37	-29	-3.15
40	-82	4	-3.13
45	-52	-54	-3.11
35	-53	-50	-3.04
39	-56	-58	-2.83
33	-28	58	-3.02
-55	-57	2	-3.01
-45	-63	4	-2.99
-25	-64	9	-2.9
-37	56	-12	-2.89
-36	-89	-6	-2.86
68	-31	-19	-2.82


//STUDYID	Hooker 2011		
//URL			
//Title	Theory of mind skills are related to gray matter volume in the ventromedial prefrontal cortex in schizophrenia		
//CORRECTED			
//MNI			
//DESCRIPTION	Whole-brain analysis of between-group differences showing regions where schizophrenia participants have less gray matter volume (GMV) as compared to healthy control participants (threshold: p<.05, FWE with 20 oxel (160mm) cluster extent)		
//STRUCTURAL			
//NO_FLIPX			
//CENSOR=			
//COVARIATE=			
//TDOF=	36		
//CONTRASTID			
//CONDITIONID			
//			
//CONTROLS=	17		
//SUBJECTS=	21		
-4	54	-12	-7.85
-54	38	-4	-7.79
38	-28	66	-7.72
-8	-78	-22	-7.33
-66	-24	-12	-7.26
-54	-58	-18	-7.23
68	-4	6	-7.08
62	10	12	-6.99
4	50	32	-6.95
-4	52	8	-6.73
-2	56	22	-6.66



//STUDYID	Jayakumar 2005		
//URL			
//Title	Optimized voxel-based morphometry of gray matter volume in first-episode, antipsychotic-naRve schizophrenia		
//CORRECTED			
//TAL			
//DESCRIPTION	Table 1 Regions of gray matter volume deficits in first-episode, antipsychotic-naRve schizophrenia patients (n =18) in comparison to matched healthy subjects (n =18)		
//STRUCTURAL			
//NO_FLIPX			
//CENSOR=			
//COVARIATE=			
//TDOF=	34		
//CONTRASTID			
//CONDITIONID			
//			
//CONTROLS=	18		
//SUBJECTS=	18		
25	13	-19	-5.22
-43	9	-5	-4.99
-47	-17	8	-4.75
12	13	5	-4.42
-11	8	5	-4.15
-15	-20	40	-4.06
-58	-36	47	-3.78
-29	65	-3	-3.62
-5	-78	-18	-3.47
-64	-14	22	-3.4

//STUDYID	Job 2002		
//URL			
//Title	Structural Gray Matter Differences between First-Episode Schizophrenics and Normal Controls Using Voxel-Based Morphometry		
//CORRECTED			
//TAL			
//DESCRIPTION	TABLE 2 The Primary VBM Study		
//STRUCTURAL			
//NO_FLIPX			
//CENSOR=			
//COVARIATE=			
//NOT_GIVEN			
//CONTRASTID			
//CONDITIONID			
//			
//CONTROLS=	36		
//SUBJECTS=	34		
3.96	40.87	1.64	-1
3.96	45.83	-15.75	-1
-55.44	-4.46	-11.55	-1
-63.36	-12.64	19.06	-1
-45.54	-0.42	-8.39	-1
-11.88	-0.84	-16.78	-1
-19.8	-5.05	-23.3	-1
55.44	-22.98	6.68	-1

//STUDYID	Kaprek 2007		
//URL			
//Title	Prefrontal but not temporal grey matter changes in males with first-episode schizophrenia		
//UNCORRECTED			
//MNI			
//DESCRIPTION	Table 4 Areas of grey matter volume reduction		
//STRUCTURAL			
//NO_FLIPX			
//CENSOR=	3.09		
//COVARIATE=			
//	
//CONTRASTID			
//CONDITIONID			
//			
//CONTROLS=	18		
//SUBJECTS=	22		
-44	56	2	-1
-32	35	-14	-1
43	58	4	-1
35	8	55	-1
47	43	-15	-1
2	20	64	-1
1	39	48	-1






//STUDYID	Kawasaki 2004		
//URL			
//Title	Structural brain differences in patients with schizophrenia and schizotypal disorder demonstrated by voxel-based morphometry		
//CORRECTED			
//TAL			
//DESCRIPTION	Table 2 Diagnosis related regional findings of gray matter concentration using SPM99 T statistics		
//STRUCTURAL			
//NO_FLIPX			
//CENSOR=			
//COVARIATE=			
//TDOF=	73		
//CONTRASTID			
//CONDITIONID			
//			
//CONTROLS=	50		
//SUBJECTS=	25 
4.00 44.00 24 -6.21
-2.00 57.00 8 -6.39
1.00 54.00 6 -6.58
-1.00 36.00 26 -5.48
2.00 22.00 41 -5.79
-50.00 15.00 32 -8.11
-31.00 59.00 20 -5.57
-48.00 42.00 13 -5.89
-41.00 24.00 -10 -6.65
39.00 27.0 -14 -6.43
-30.00 42.00 -21 -5.72
-41.00 -3.00 5 -5.57
-46.00 -10.00 8 -5.32
-57.00 -20.00 14 -5.49
-18.00 -7.00 -19 -6.58
17.00 -6.00 -22 -5.76
1.00 5.00 -3 -5.58
-1.00 54.00 19 -6.52





//STUDYID	Kawasaki 2007		
//URL			
//Title	Multivariate voxel-based morphometry successfully differentiates schizophrenia patients from healthy controls		
//CORRECTED			
//MNI			
//DESCRIPTION	Table 2 Reduced gray matter concentration using SPM99 T-statistic		
//STRUCTURAL			
//NO_FLIPX			
//CENSOR=			
//COVARIATE=			
//TDOF=	58		
//CONTRASTID			
//CONDITIONID			
//			
//CONTROLS=	30		
//SUBJECTS=	30		
-3	33	21	-5.26
7	38	25	-6.68
6	50	11	-5.98
-45	12	28	-5.61
-35	17	-6	-7.34
44	20	-6	-5.64
-46	2	8	-5.16
40	13	0	-6.4
-53	-10	-15	-5.87



//STUDYID	Kubicki 2002		
//URL			
//Title	Voxel-Based Morphometric Analysis of Gray Matter in First Episode Schizophrenia		
//CORRECTED			
//TAL			
//DESCRIPTION	TABLE 2 Areas of Reduced Regional Gray Matter Density		
//STRUCTURAL			
//NO_FLIPX			
//CENSOR=			
//COVARIATE=			
//ZSCORE			
//CONTRASTID			
//CONDITIONID			
//			
//CONTROLS=	18		
//SUBJECTS=	16		
38	22	3	-4.15
-6	2	40	-4.32
9	14	33	-4.47
-60	-28	11	-5.27
61	-12	10	-4.12
-46	-8	12	-4.58
39	9	4	-3.92
35	-34	44	-4.85
-18	-39	1	-4.34

//STUDYID	Lei 2015		
//URL			
//Title	Gray Matter Volume Alterations in First-episode Drug-nave Patients with Deficit and Nondeficit Schizophrenia		
//CORRECTED			
//MNI			
//DESCRIPTION	Table 2 Voxel-wise comparisons of GMV between groups		
//STRUCTURAL			
//NO_FLIPX			
//CENSOR=			
//COVARIATE=			
//TDOF=	170		
//CONTRASTID			
//CONDITIONID			
//			
//CONTROLS=	84		
//SUBJECTS=	88		
10	-62	-26	-5.2




//STUDYID	Liao 2015		
//URL			
//Title	Reduced paralimbic system gray matter volume in schizophrenia: Correlations with clinical variables, symptomatology and cognitive function		
//CORRECTED			
//MNI			
//DESCRIPTION	Table 2 Areas of reduced gray matter volume in schizophrenic patients compared with healthy controls (P < 0.05, FWE corrected, cluster size >20).		
//STRUCTURAL			
//NO_FLIPX			
//CENSOR=			
//COVARIATE=			
//TDOF=	190		
//CONTRASTID			
//CONDITIONID			
//			
//CONTROLS=	99		
//SUBJECTS=	93		
0	38	-15	-6.26
2	44	-6	-5.56
9	35	-20	-5.43
45	-10	-8	-6.18
42	-13	-15	-5.73
48	12	-9	-5.72
-44	-12	-8	-5.52
-41	6	-15	-5.33
-45	-6	-14	-5.03
33	11	-23	-5.16
-56	-7	4	-5.09
-33	26	-2	-4.89


//STUDYID	Martinot 2001		
//URL			
//Title	Cerebral Gray and White matter reductions and clinical correlates in patients with early onset schizophrenia		
//CORRECTED			
//TAL			
//DESCRIPTION	Table 3 Regions of reduced regional gray matter		
//STRUCTURAL			
//NO_FLIPX			
//CENSOR=			
//COVARIATE=			
//ZSCORE			
//CONTRASTID			
//CONDITIONID			
//			
//CONTROLS=	20		
//SUBJECTS=	20		
-40	4	8	-4.74
-40	22	2	-4.57
-58	3	8	-3.73
-8	56	10	-4.19
-6	39	-12	-3.11
-34	-42	-20	-3.98
-33	-51	-16	-3.86
-22	54	9	-3.9


//STUDYID	Marcelis 2003		
//URL			
//Title	Searching for a structural endophenotype in psychosis using computational morphometry		
//CORRECTED			
//TAL			
//DESCRIPTION	Table 3		
//STRUCTURAL			
//NO_FLIPX			
//CENSOR=			
//COVARIATE=			
//NOT_GIVEN			
//CONTRASTID			
//CONDITIONID			
//			
//CONTROLS=	27		
//SUBJECTS=	31		
4.8	18.6	6.6	-1
0.5	17.2	42.2	-1
-35.7	9.9	12.9	-1
-7.3	-16.1	7.2	-1
-26	-53.6	-55.9	-1
22	-55.9	-59.1	-1
1.6	3.1	54.3	-1
-38.8	3.9	13	-1
3.2	-41.1	45.5	-1
4	-59.5	21.9	-1


//STUDYID	McIntosh 2004		
//URL			
//Title	Voxel-Based Morphometry of Patients with Schizophrenia or Bipolar Disorder and Their Unaffected Relatives		
//CORRECTED			
//TAL			
//DESCRIPTION	Table 2. VBM Analysis of Patients Versus Controls Table 3. Reductions in Gray Matter in Schizophrenic Patients Compared with Their Unaffected Relatives		
//STRUCTURAL			
//NO_FLIPX			
//CENSOR=			
//COVARIATE=			
//NOT_GIVEN			
//CONTRASTID			
//CONDITIONID			
//			
//CONTROLS=	49		
//SUBJECTS=	71		
-41	12	48	-1
-34	31	40	-1
-50	11	21	-1
-31	-48	-5	-1
-58	-39	20	-1
-58	-33	5	-1
-53	-15	36	-1


//STUDYID	Molina 2011		
//URL			
//Title	Different gray matter patterns in chronic schizophrenia and chronic bipolar disorder patients identified using voxel-based morphometry		
//UNCORRECTED			
//MNI			
//DESCRIPTION	Table 2 Location, peak coordinates and t value of the local maxima and voxel extent of the GM differences between each pair of groups (P\0.001 uncorrected in all cases)		
//STRUCTURAL			
//NO_FLIPX			
//CENSOR=	3.09		
//COVARIATE=			
//TDOF=	50		
//CONTRASTID			
//CONDITIONID			
//			
//CONTROLS=	24		
//SUBJECTS=	28		
-2	46	36	-4.89
24	8	3	-4.05



//STUDYID	Moorhead 2004		
//URL			
//Title	Voxel-based morphometry of comorbid schizophrenia and learning disability: analyses in normalized and native spaces using parametric and nonparametric statistical methods		
//CORRECTED			
//MNI			
//DESCRIPTION	Table 4 Normalized space: normal controls > schizophrenics		
//STRUCTURAL			
//NO_FLIPX			
//CENSOR=			
//COVARIATE=			
//TDOF=	47		
//CONTRASTID			
//CONDITIONID			
//			
//CONTROLS=	29		
//SUBJECTS=	25		
-62	-3	0	-5.33
60	-4	6	-4.93
8	-81	14	-5
-13	-100	14	-4.92
17	41	53	-4.96

//STUDYID	Nakamura 2013		
//URL			
//Title	Gray matter changes in subjects at high risk for developing psychosis and first-episode schizophrenia: a voxel-based structural MRI study		
//CORRECTED			
//TAL			
//DESCRIPTION	Table 2 |Talairach coordinates for regions of reduced gray matter volume in the schizophrenia patients compared to the healthy controls		
//STRUCTURAL			
//NO_FLIPX			
//CENSOR=			
//COVARIATE=			
//TDOF=	83		
//CONTRASTID			
//CONDITIONID			
//			
//CONTROLS=	51		
//SUBJECTS=	34		
-11	42	8	-3.82



//STUDYID	Ohnishi 2006		
//URL			
//Title	The association between the Val158Met polymorphism of the catechol-O-methyl transferase gene and morphological abnormalities of the brain in chronic schizophrenia		
//CORRECTED			
//TAL			
//DESCRIPTION	Table 2 Results of image analyses		
//STRUCTURAL			
//NO_FLIPX			
//CENSOR=			
//COVARIATE=			
//TDOF=	121		
//CONTRASTID			
//CONDITIONID			
//			
//CONTROLS=	76		
//SUBJECTS=	47		
33	11	-2	-6.41
-33	11	4	-8.81
30	1	-17	-7.32
30	-41	-8	-5.04
-20	-41	-8	-5.46
9	33	20	-4.9
-11	32	20	-4.63
-12	-16	39	-4.2
27	28	-11	-4.99
12	43	39	-6.08
-8	47	19	-5.13
-44	23	15	-4.55
-30	24	43	-4.44
-35	17	51	-4.39
41	13	45	-4.37
47	-23	-1	-5.04
56	-15	3	-4.87
-36	1	-17	-7
-15	-17	2	-7.26

//STUDYID	Salgado-Pineda 2003		
//URL			
//Title	Sustained attention impairment correlates to gray matter decreases in first episode neuroleptic-naive schizophrenic patients		
//CORRECTED			
//TAL			
//DESCRIPTION	Table 3 VBM study: GM decreases in schizophrenia patients		
//STRUCTURAL			
//NO_FLIPX			
//CENSOR=3.09			
//COVARIATE=			
//NOT_GIVEN			
//CONTRASTID			
//CONDITIONID			
//			
//CONTROLS=	13		
//SUBJECTS=	13		
-12	10	11	-1
-12	-28	56	-1
-5	-18	8	-1
5	-16	8	-1
12	10	10	-1
11	18	1	-1
-9	-51	-10	-1
9	24	33	-1
10	32	25	-1
-29	-53	-10	-1
-32	-20	-16	-1
-32	-35	-10	-1
31	2	1	-1
-43	19	-7	-1
-3	-69	-19	-1


//STUDYID	Salgado-Pineda 2004		
//URL			
//Title	Decreased cerebral activation during CPT performance: structural and functional deficits in schizophrenic patients		
//CORRECTED			
//TAL			
//DESCRIPTION			
//STRUCTURAL			
//NO_FLIPX			
//CENSOR=			
//COVARIATE=			
//NOT_GIVEN			
//CONTRASTID			
//CONDITIONID			
//			
//CONTROLS=	14		
//SUBJECTS=	14		
40	55	18	-1
50	40	22	-1
31	65	-1	-1
12	19	46	-1
-5	63	-14	-1
-50	15	36	-1
-43	54	14	-1
-36	64	13	-1
-12	34	42	-1
-40	15	45	-1
51	-82	15	-1
60	-63	11	-1
56	-25	52	-1
64	-23	28	-1
-60	-61	10	-1
-64	-28	24	-1
-50	-39	56	-1
-63	-14	16	-1
-45	-45	32	-1
52	-50	-15	-1
46	-16	-27	-1
-63	-22	-19	-1
-66	-3	-9	-1
10	-1	40	-1
-8	10	35	-1
-4	17	22	-1
26	-23	-16	-1
26	-46	-6	-1
-10	-20	-16	-1
20	-18	12	-1
-18	-19	17	-1
-16	-20	1	-1
16	-14	23	-1
-4	12	-2	-1
-49	-20	-26	-1
-34	-42	-18	-1
47	-30	-22	-1
-55	-55	-25	-1

//STUDYID	Shapleske 2002		
//URL			
//Title	A Computational Morphometric MRI Study of Schizophrenia: Effects of Hallucinations		
//CORRECTED			
//TAL			
//DESCRIPTION	Table 3 Regional proportional tissue volume differences between schizophrenia patients (combined) versus controls		
//STRUCTURAL			
//NO_FLIPX			
//CENSOR=			
//COVARIATE=			
//NOT_GIVEN			
//CONTRASTID			
//CONDITIONID			
//			
//CONTROLS=	32		
//SUBJECTS=	72		
-2	28	-15	-1
17	-2	-25	-1
-42	-3	8	-1
3	-4	4	-1
-20	-8	-15	-1
41	-8	3	-1
-4	-66	32	-1
3	-67	24	-1
-3	-67	23	-1

//STUDYID	Sigmundsson 2001		
//URL			
//Title	Structural Abnormalities in Frontal, Temporal, and Limbic Regions and Interconnecting White Matter Tracts in Schizophrenic Patients With Prominent Negative Symptoms 		
//CORRECTED			
//TAL			
//DESCRIPTION	TABLE 3. Gray Regional Differences Between Schizophrenic Patients With Prominent Negative Symptoms (N=27) and Healthy Comparison Subjects (N=27)		
//STRUCTURAL			
//NO_FLIPX			
//CENSOR=			
//COVARIATE=			
//NOT_GIVEN			
//CONTRASTID			
//CONDITIONID			
//			
//CONTROLS=	27		
//SUBJECTS=	27		
-38	-4	-7	-1
-0.5	46	1	-1
-29	-6	-26	-1
-26	-3.6	-12	-1


//STUDYID	Stegmayer 2014		
//URL			
//Title	Ventral striatum gray matter density reduction in patients with schizophrenia and psychotic emotional dysregulation		
//CORRECTED			
//MNI		
//DESCRIPTION	Table 3 Regions with significant group differences in brain density (all patients b healthy controls)		
//STRUCTURAL			
//NO_FLIPX			
//CENSOR=			
//COVARIATE=			
//TDOF=	75		
//CONTRASTID			
//CONDITIONID			
//			
//CONTROLS=	34		
//SUBJECTS=	43		
10	-16	14	-3.95
-24	34	-20	-4.28
-4	40	-22	-4.21
4	48	-20	-3.34
10	60	0	-3.88
-26	14	-38	-4.19


//STUDYID	Suzuki 2002		
//URL			
//Title	Regional changes in brain gray and white matter in patients with schizophrenia demonstrated with voxel-based analysis of MRI		
//CORRECTED			
//TAL			
//DESCRIPTION	Table 1. Brain regions in which voxels showed significant regional gray matter changes in patients with schizophrenia compared with controls		
//STRUCTURAL			
//NO_FLIPX			
//CENSOR=			
//COVARIATE=			
//ZSCORE			
//CONTRASTID			
//CONDITIONID			
//			
//CONTROLS=	42		
//SUBJECTS=	45		
-52	10	32	-5.7
4	30	28	-5.66
30	-22	-14	-4.26
50	42	6	-3.97
-18	-6	-20	-3.94
-52	8	34	-4.35
-4	32	28	-4.08
0	36	22	-4.62
32	56	14	-4.17



//STUDYID	Tae Hyon Ha 2004		
//URL			
//Title	Gray matter abnormalities in paranoid schizophrenia and their clinical correlations		
//CORRECTED			
//TAL			
//DESCRIPTION	Table 2 Regions of reduced gray matter concentrations n patients with paranoid schizophrenia compared with controls		
//STRUCTURAL			
//NO_FLIPX			
//CENSOR=			
//COVARIATE=			
//ZSCORE			
//CONTRASTID			
//CONDITIONID			
//			
//CONTROLS=	35		
//SUBJECTS=	35		
4	50	-8	-6.18
0	42	14	-5.36
2	9	-12	-5.02
-41	19	-1	-5.9
-50	-5	2	-5.17
-44	-9	6	-4.99
-48	-19	-28	-5.27
59	16	7	-5.54
50	10	-4	-4.99
40	21	-9	-4.8
65	-27	0	-5.46
-34	53	18	-5.19
-34	56	1	-5.1

//STUDYID	Wang 2017		
//URL			
//Title	Gray matter morphological anomalies in the cerebellar vermis in first-episode schizophrenia patients with cognitive deficits		
//CORRECTED			
//MNI			
//DESCRIPTION	Table 2 Regions showing gray matter density among SZ-NCD, SZ-CD, and control group		
//STRUCTURAL			
//NO_FLIPX			
//CENSOR=			
//COVARIATE=			
//ZSCORE			
//CONTRASTID			
//CONDITIONID			
//			
//CONTROLS=	21		
//SUBJECTS=	34		
-11	-57	-70	-4.04
68	-8	6	-3.11
-26	8	2	-2.84
-11	21	-2	-4.49
-21	-5	-27	-3.97
-42	-59	-48	-3.22





//STUDYID	Whitford 2005		
//URL			
//Title	Grey matter deficits and symptom profile in first episode schizophrenia		
//CORRECTED			
//TAL			
//DESCRIPTION	Table 1. Descriptive details of the four regions of grey matter volume reduction in 31 patients with first episode schizophrenia relative to matched healthy controls (P < 0.05 corrected for multiple comparisons, extent threshold = 400 voxels)	
//STRUCTURAL			
//NO_FLIPX			
//CENSOR=			
//COVARIATE=			
//NOT_GIVEN			
//CONTRASTID			
//CONDITIONID			
//			
//CONTROLS=	30		
//SUBJECTS=	31		
-29	52	-3	-1
-9	46	3	-1
-9	41	14	-1
-65	-27	14	-1
-55	-18	45	-1
-59	-24	40	-1
29	-50	-32	-1
33	-59	-32	-1
44	-45	-28	-1
56	-12	45	-1
64	-10	19	-1
61	3	16	-1



//STUDYID	Whitford 2006		
//URL			
//Title	Progressive grey matter atrophy over the first 23 years of illness in first-episode schizophrenia: A tensor-based morphometry study		
//CORRECTED			
//TAL			
//DESCRIPTION	Table 2. Baseline studyregions where the 41 FES patients had less GM at baseline than did the 47 matched healthy controls (statistically controlling for age, gender, handedness, and global GM volume)		
//STRUCTURAL			
//NO_FLIPX			
//CENSOR=			
//COVARIATE=			
//TDOF=	86		
//CONTRASTID			
//CONDITIONID			
//			
//CONTROLS=	47		
//SUBJECTS=	41		
64	-2	27	-8.17
61	7	26	-8.05
60	-11	42	-7.22
30	-60	-4	-7.48
-32	51	-7	-7.45
-27	52	8	-6.76
-38	43	-6	-6.38
-62	21	37	-7.34
-60	-15	41	-7.14
-68	-32	-3	-6.91
-17	25	-14	-6.22
-26	28	-13	-5.77
-11	36	17	-5.77
39	-42	-27	-5.2


//STUDYID	Wilke 2001		
//URL			
//Title	Gray Matter-Changes and Correlates of Disease Severity in Schizophrenia: A Statistical Parametric Mapping Study		
//CORRECTED			
//TAL			
//DESCRIPTION	TABLE 2 Talairach Coordinates of Significant Clusters		
//STRUCTURAL			
//NO_FLIPX			
//CENSOR=	3.09		
//COVARIATE=			
//NOT_GIVEN			
//CONTRASTID			
//CONDITIONID			
//			
//CONTROLS=	48		
//SUBJECTS=	48		
59	7	-9	-1
51	14	-23	-1
59	6	-5	-1
63	0	-3	-1
-65	-7	6	-1
-44	16	1	-1
-40	19	-9	-1
-50	31	-8	-1
-4	45	-24	-1
-2	56	1	-1
-2	54	-6	-1


//STUDYID	Wright 1999		
//URL			
//Title	Mapping of grey matter changes in schizophrenia		
//UNCORRECTED			
//TAL			
//DESCRIPTION	Table 3.Areas of reduced regionalgrey matterinschizophrenicscompared with controls		
//STRUCTURAL			
//NO_FLIPX			
//CENSOR=			
//COVARIATE=			
//NOT_GIVEN			
//CONTRASTID			
//CONDITIONID			
//			
//CONTROLS=	15		
//SUBJECTS=	15		
-28	12	-20	-4.4
-46	14	36	-4.2
-46	14	0	-4.1
-48	6	-4	-3.9
-34	16	-12	-3.8
28	12	-20	-5
44	8	-8	-3.5
42	18	0	-3.2
24	-12	-12	-3.1



//STUDYID	Xu 2009		
//URL			
//Title	Source-Based Morphometry: The Use of Independent Component Analysis to Identify Gray Matter Differences With Application to Schizophrenia		
//UNCORRECTED			
//MNI			
//DESCRIPTION	TABLE II Talairach labels for the result of VBM		
//STRUCTURAL			
//NO_FLIPX			
//CENSOR=	3		
//COVARIATE=			
//ZSCORE			
//CONTRASTID			
//CONDITIONID			
//			
//CONTROLS=	120		
//SUBJECTS=	120		
-6	-9	2	-5
7	-9	-2	-6.5
-36	6	-3	-5.4
34	10	-2	-4.1
-34	16	-5	-5.2
40	17	-8	-4.4
-34	12	-1	-4.9
34	14	-6	-4.7
-36	2	-13	-4.8
33	1	-18	-3.9
-12	-8	53	-4
7	46	-14	-4.7
-30	4	-14	-4.7
21	-31	-6	-4.1
-58	-9	18	-4.7
56	-14	17	-3.6
-61	-20	-15	-4.3
62	-18	-17	-3.5
-28	0	-21	-4.3
30	-8	-36	-3.7
-28	-78	20	-3.7
31	-79	21	-4.3
-25	25	-18	-4.2
43	39	-10	-3.9
-12	-42	39	-4
12	-4	43	-4.2
-30	55	-4	-3.3
16	38	31	-4.1
-9	48	-2	-4
10	35	20	-3.7
-64	-22	-11	-3.9
40	-68	30	-3.5
-59	-4	17	-3.8
49	11	6	-3.4
-22	-73	19	-3.8
27	-76	18	-3.5
-33	-43	44	-3.7
53	-44	26	-3.5
-3	41	-20	-3.1
19	32	-22	-3.7
10	-87	10	-3.6
9	38	-20	-3.5
-42	-30	13	-3.5
62	-11	14	-3.2
-30	-83	22	-3.1
33	-79	26	-3.4
-46	-71	33	-3
39	-74	31	-3.3
-40	-80	-4	-3.2
33	-82	-3	-3
25	5	-12	-3.2
-55	-45	23	-3.1
49	-47	29	-3
-42	-64	54	-3.1
-56	-17	-23	-3.1



//STUDYID	Zhang 2017		
//URL			
//Title	Diferential Cortical Gray Matter Defcits in Adolescent- and AdultOnset First-Episode TreatmentNave Patients with Schizophrenia		
//CORRECTED			
//MNI
//DESCRIPTION	Table 2. Gray matter volume comparison between drug-nave, frst-episode schizophrenia patients and healthy controls		
//STRUCTURAL			
//NO_FLIPX			
//CENSOR=			
//COVARIATE=			
//ZSCORE			
//CONTRASTID			
//CONDITIONID			
//			
//CONTROLS=	83		
//SUBJECTS=	75		
-10	-38	69	-4.81
-13	-35	70	-4.42
-14	1	73	-4.71
38	-11	66	-4.03
54	-29	-5	-4.53
31	-91	-1	-4.26
14	-95	0	-3.76
4	-71	-31	-3.77



